Search

Your search keyword '"Fernandez, M.E. Elez"' showing total 20 results
Start Over Author "Fernandez, M.E. Elez"
20 results on '"Fernandez, M.E. Elez"'

1. 99P Molecular correlates and treatment outcomes of patients with brain metastasis included in early phase trials: A single-center retrospective analysis

Author

Pretelli, G., primary, Laimito, K.I. Rojas, additional, Casal, G. Alonso, additional, Bardaji, M.J. Lostes, additional, Calvo, A. Hernando, additional, Galvao, V., additional, Oberoi, A., additional, Morillo, B. Ortega, additional, Mirallas, O., additional, Santa Gadea, O. Saavedra, additional, Manich, C. Saura, additional, Fernandez, M.E. Elez, additional, Ortiz, C., additional, Couselo, E. Muñoz, additional, Braña, I., additional, Galceran, J.C., additional, Felip, E., additional, Garralda, E., additional, and Villar, M. Vieito, additional

Published
2024
Full Text
View/download PDF

2. 116TiP Randomized, open-label, phase II study of botensilimab (BOT) alone and in combination with balstilimab (BAL) versus standard-of-care in patients with refractory metastatic colorectal cancer

Author

Van Cutsem, E., primary, Fakih, M., additional, Segal, N.H., additional, Johnson, B., additional, Kardosh, A., additional, Philipovskiy, A., additional, Krishnamurthi, S., additional, Gold, P.J., additional, Dekervel, J., additional, Schlechter, B.L., additional, Grossman, J., additional, Fernandez, M.E. Elez, additional, Vardiashvili, N., additional, Azambuja, A.A., additional, Eng, C., additional, Ducreux, M.P., additional, André, T., additional, Tabernero, J., additional, Lenz, H.J., additional, and Hidalgo, M., additional

Published
2023
Full Text
View/download PDF

3. 526P Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: A FRESCO-2 subgroup analysis by age.

Author

Fernandez, M.E. Elez, Dasari, N.A., Lonardi, S., Eng, C., Garcia-Carbonero, R., Yoshino, T., Sobrero, A., Yao, J.C., Alfonso, P. García, Kocsis, J., Gracian, A. Cubillo, Bianchi, A. Sartore, Satoh, T., Randrian, V., Cremolini, C., Yang, Z., Schelman, W., Zhu, H., Chen, L., and Tabernero, J.

Subjects
*COLORECTAL cancer, *METASTASIS, *SUBGROUP analysis (Experimental design), *AGE, *SAFETY
Published
2024
Full Text
View/download PDF

4. LBA25 FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer

Author

Dasari, N.A., primary, Lonardi, S., additional, Garcia-Carbonero, R., additional, Fernandez, M.E. Elez, additional, Yoshino, T., additional, Sobrero, A.F., additional, Yao, J.C., additional, García-Alfonso, P., additional, Kocsis, J., additional, Gracian, A. Cubillo, additional, Bianchi, A. Sartore, additional, Satoh, T., additional, Randrian, V., additional, Tomasek, J., additional, Chong, G., additional, Yang, Z., additional, Schelman, W., additional, Kania, M., additional, Tabernero, J., additional, and Eng, C., additional

Published
2022
Full Text
View/download PDF

5. LBA26 BREAKWATER safety lead-in (SLI): Encorafenib (E) + cetuximab (C) + chemotherapy (chemo) for BRAFV600E metastatic colorectal cancer (mCRC)

Author

Tabernero, J., primary, Yoshino, T., additional, Kim, T.W., additional, Yaeger, R., additional, Desai, J., additional, Wasan, H.S., additional, Van Cutsem, E., additional, Ciardiello, F., additional, Maughan, T., additional, Eng, C., additional, Tie, J., additional, Fernandez, M.E. Elez, additional, Lonardi, S., additional, Zhang, X., additional, Chavira, R., additional, Usari, T., additional, Hahn, E., additional, and Kopetz, S., additional

Published
2022
Full Text
View/download PDF

6. LBA27 Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC

Author

Strickler, J.H., primary, Cercek, A., additional, Siena, S., additional, André, T., additional, Ng, K., additional, Van Cutsem, E., additional, Wu, C., additional, Paulson, A.S., additional, Hubbard, J., additional, Coveler, A., additional, Fountzilas, C., additional, Kardosh, A., additional, Kasi, P.M., additional, Lenz, H.J., additional, Ciombor, K.K., additional, Fernandez, M.E. Elez, additional, Bajor, D.L., additional, Stecher, M., additional, Feng, W., additional, and Bekaii-Saab, T., additional

Published
2022
Full Text
View/download PDF

7. 127P Clinical utility of circulating tumor DNA (ctDNA) next generation sequencing (NGS) to inform treatment decisions for patients (pts) with advanced solid tumors

Author

Puerto, D.A. Gomez, Rossi, A., Calvo, A. Hernando, Hermida, J.M. Ucha, Gómez, M., Matito, J., Vila-Casadesús, M., Araujo, D. Morchón, Dienstmann, R., Galceran, J.C., Illescas, D.G., Mercade, T. Macarulla, Garralda, E., Manich, C. Saura, Fernandez, M.E. Elez, Felip, E., Tabernero, J., and Vivancos, A.

Published
2024
Full Text
View/download PDF

8. 588P Genomic landscape of acquired resistance to first-line (1L) anti-EGFR treatment in metastatic colorectal cancer (mCRC) beyond the classical EGFR pathway: Findings from the PLATFORM-B study

Author

Martelli, V., Barrull, J. Vidal, Rodriguez, C. Fernandez, Toledo, R.D.A., Gibert, J., Alfonso, P. García, Paez, D., Alonso-Orduna, V., Gomez España, M.A., Vivas, C. Santos, Ogaya, G. Duran, Fernandez, M.E. Elez, Garcia-Carbonero, R., Monteagudo, R. Ferreiro, Mozo, J.L. Manzano, Paricio, B. Bellosillo, Tabernero, J., Soler, R. Salazar, Aguilar, E. Aranda, and Viladot, C. Montagut

Published
2024
Full Text
View/download PDF

9. 579P Intratumoral fusobacterium as prognostic factor in early stage colorectal cancer: Results of the FUSOMAP study

Author

Nuciforo, P.G., Navarro, F. Moratalla, Argota, I. Baraibar, Alonso, L., serna, G., Barrull, J. Vidal, Castro, L. Aguilera, Margalef, N. Mulet, Montes, A. Fernandez, Cuatrecasas, M., Gonzalez, I. Gardeazabal, Gonzalez, E., Alfonso, P. García, Keranen, S. Rosello, Comas, R., Puxan, N. Bayo, FASANI, R., Obon, M., Fernandez, M.E. Elez, and Aguado, V. Moreno

Published
2024
Full Text
View/download PDF

11. 541P Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Subgroup efficacy and expanded safety analyses from CheckMate 8HW

Author

André, T., Lonardi, S., Lenz, H.J., Jensen, L.H., Van Cutsem, E., Touchefeu, Y., Garcia-Carbonero, R., Tougeron, D., Mendez, G.A., Schenker, M., Fouchardiere, C. de la, Limon, M.L., Yoshino, T., Li, J., Mozo, J.L. Manzano, Cela, E., Chen, T., Lei, M., Jin, L., and Fernandez, M.E. Elez

Published
2024
Full Text
View/download PDF

14. 445P Tumor load surrogates as major prognostic factors in BRAF-V600E mutated (mt) colorectal (CRC) patients treated with BRAF inhibitor+antiEGFR +/- MEK inhibitor

Author

Montana, F.J. Ros, primary, Martini, G., additional, Javierre, G. Villacampa, additional, Baraibar, I., additional, Comas, R., additional, Garcia, A., additional, Salva, F., additional, Gonzalez, N. Saoudi, additional, Ciardiello, D., additional, Toledo, R.D.A., additional, Martinelli, E., additional, Ciardiello, F., additional, Vivancos, A., additional, Palmer, H.G., additional, Dienstmann, R., additional, Tabernero, J., additional, and Fernandez, M.E. Elez, additional

Published
2021
Full Text
View/download PDF

15. 1724P Prognostic parameters at admission as predictors of hospital length of stay (HLOS) and overall survival (OS) in hospitalized oncologic patients (pts) of a tertiary hospital

Author

Mirallas, O., primary, López-Valbuena, D., additional, Javierre, G. Villacampa, additional, Vega, K.S., additional, Gómez-Puerto, D., additional, Salva-Torres, C., additional, Rezqallah, A., additional, Molina, G., additional, Aguilar-Company, J., additional, Roca, M., additional, Andurell, L., additional, Palmas, F., additional, Fernandez, M.E. Elez, additional, Alonso, A., additional, Gomez-Pardo, P., additional, Serradell, S., additional, Tabernero, J., additional, Felip, E., additional, Peñuelas, A., additional, and Carles, J., additional

Published
2021
Full Text
View/download PDF

16. 442P A phase I-II multicenter trial with avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients. GEMCAD 16-02 (AVEVAC trial)

Author

Español-Rego, M., primary, Fernández-Martos, C., additional, Fernandez, M.E. Elez, additional, Foguet, C., additional, Pedrosa, L., additional, Rodríguez, N., additional, Ruiz, A., additional, Pineda, E., additional, Cid, J., additional, Cabezón, R., additional, Oliveres, H., additional, Lozano, M., additional, Ginés, A., additional, Garcia-Criado, A., additional, Cuatrecasas, M., additional, Torres, F., additional, Cascante, M., additional, Benítez-Ribas, D., additional, and Maurel, J., additional

Published
2021
Full Text
View/download PDF

19. 538P Single-center retrospective analysis of patients with brain metastases included in early phase clinical trials

Author

Pretelli, G., Laimito, K.I. Rojas, Alonso, G., Bardaji, M.J. Lostes, Calvo, A. Hernando, Galvao, V., Oberoi, A., Morillo, B. Ortega, Santa Gadea, O. Saavedra, Moya, J. Ginard, Manich, C. Saura, Fernandez, M.E. Elez, Ortiz, C., Couselo, E. Muñoz, Braña, I., Perez, A. Callejo, Galceran, J. Carles, Felip, E., Garralda, E., and Villar, M. Vieito

Published
2023
Full Text
View/download PDF

20. CN52 Role of translational oncology research nurse (TORN) in improving patients (pts) adherence to microbiome research projects

Author

Rodriguez, A. Garcia, Castillo, G., Argota, I. Baraibar, Sanchis, M., Sanz, M., Suarez, I., Ballabrera, F. Salvà, Montana, F.J. Ros, Gonzalez, N. Saoudi, Valdivia, A.A., Alonso, C. Perez, Rosales, C., Texidor, A., Castells, M. Rodriguez, Gallostra, M. Marti, Saiz, A. Peñuelas, Tabernero, J., and Fernandez, M.E. Elez

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results